India Gabapentin Market to grow at a steady rate During the Forecast Period
Growing epilepsy and restless legs syndrome is expected to drive the growth of India Gabapentin market during the forecast period. According to TechSci Research report, “ India Gabapentin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (100 mg, 200 mg, 300 mg, 400 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome (RLS), Seizures, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India Gabapentin market is expected to grow at a steady rate during the forecast period. The medication is very effective in treating hot flashes as well as neuropathic pain. Moreover, it is considered as first line medication for treating neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain which is expected to fuel the market growth through FY2026....